SCNX: Rasio silihan jangka dawa marang modal scienture.com

Lambang korporat lan logo Scienture Corp (SCNX)

Patent protection of IT infrastructure and high switching costs create a robust moat for Scienture Holdings Inc (SCNX). On GURU.Markets, this line chart of the long-term debt-to-equity ratio demonstrates market dynamics where the value of 0.15 reflects this status. Stable administrative resources and ISO compliance strengthen its position, while premium pricing for unique drug delivery methods ensures high margins.

Scienture Holdings Inc. (SCNX) - Utang jangka dawa marang ekuitas saka 24.09.2024 nganti 31.10.2026
Produk asli Scienture Holdings

This metric determines the dependence of long-term financing on the volume of equity, reflecting the operational resilience of the business. The indicator measures the share of loans with a maturity of over one year relative to equity to assess financial leverage. Scienture Holdings Inc (SCNX), as a medical software developer, minimizes environmental risks and capital expenditures on production. This allows the company to maintain a low level of borrowing. The trend in the ratio of liabilities over one year to equity confirms the issuer's margin of safety.

Pesaing wigati

Veeva Systems (VEEV) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas DOCS (Doximity Corp)|Rasio silihan jangka dawa marang modal HQY|Waystar Holding Corp. - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CRVL|PRVA - Utang jangka dawa marang ekuitas|Huron Consulting Group Inc. (HURN) - Rasio utang jangka dawa marang ekuitas|CERT: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Omnicell Health (OMCL)|GDRX (GoodRx Holdings, Inc.) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal SDGR (schrodinger.com)|Utang jangka dawa marang ekuitas Phreesia (PHR)|Rasio tanggungan utang jangka dawa marang modal Omada Health, Inc.|Utang jangka dawa marang modal EVH (Evolent)|HSTM - Rasio utang jangka dawa marang ekuitas|Definitive Healthcare - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal consensus.com CCSI|AGL: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Absci Corp (ABSI)|Utang jangka dawa marang ekuitas SoYoung|Rasio utang jangka dawa marang modal NRC (nrchealth.com)|Rasio utang jangka dawa marang ekuitas SPOK (Spok Holdings, Inc.)|Rasio silihan jangka dawa marang modal OPRX|TruBridge - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal Simulations Plus Inc SLP|SOPH - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal HCAT (Health Catalyst Inc)|CCLD: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal researchsolutions.com (RSSS)|Rasio utang jangka dawa marang ekuitas DLHC|ONMD: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal HCTI|ISPC (ispecimen.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Bullfrog AI BFRG|scworx.com (WORX) - Kewajiban jangka dawa marang modal|MSPR - Utang jangka dawa marang ekuitas|ICCT: Utang jangka dawa marang ekuitas|MEDS: Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal ORGS|RCM (R1 RCM, Inc.) - Utang jangka dawa marang modal|sharecare.com (SHCR) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Streamline Health (STRM)|Syra Health Corp - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal AMEH (Apollo Medical Holdings, Inc.)|Tanggungan utang jangka dawa marang ekuitas Model N Corporation|NXGN - Utang jangka dawa marang ekuitas